Cargando…

The Landscape of Clinical Implementation of Pharmacogenetic Testing in Central China: A Single-Center Study

PURPOSE: Pharmacogenetic testing is recognized as the major method for the individualized pharmacotherapy in clinical pharmacy practice, but information about the clinical implementation of pharmacogenetic testing in China is limited. The present study aimed to determine the situation of clinical im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jingmin, Qi, Guangzhao, Han, Chao, Zhou, Yubing, Yang, Yongjie, Wang, Xinru, Liu, Suna, Zhang, Xiaojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684419/ https://www.ncbi.nlm.nih.gov/pubmed/34934339 http://dx.doi.org/10.2147/PGPM.S338198

Ejemplares similares

Genetic landscape of 125 pharmacogenes in Chinese from the Chinese Millionome Database
por: Qi, Guangzhao, et al.
Publicado: (2021)

The Current Landscape of Marijuana and Pharmacogenetics
por: Rambaran, Kerry Anne, et al.
Publicado: (2017)

The landscape of pharmacogenetic testing in a US managed care population
por: Anderson, Heather D., et al.
Publicado: (2020)

Therapeutic Drug Monitoring and Pharmacogenetic Testing in Northern China
por: Zhang, Chunyan, et al.
Publicado: (2021)

Exploring Pharmacogenetic Testing for Hypertension Management in China
por: Zhao, Zhenping, et al.
Publicado: (2023)

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
por: Caudle, Kelly E., et al.
Publicado: (2017)

Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines: A Systematic Review
por: Morris, Sarah A., et al.
Publicado: (2022)

Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center
por: Pasternak, Amy L., et al.
Publicado: (2020)

Multi-site investigation of strategies for the clinical implementation of preemptive pharmacogenetic testing
por: Duarte, Julio D., et al.
Publicado: (2021)

Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)

Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementation
por: Bignucolo, A., et al.
Publicado: (2023)

Correction to: Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
Publicado: (2022)

What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
por: Jameson, Adam, et al.
Publicado: (2021)

Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States
por: Lemke, Lauren K., et al.
Publicado: (2023)

Towards the clinical implementation of pharmacogenetics in bipolar disorder
por: Salloum, Naji C, et al.
Publicado: (2014)

Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings
por: Smith, D. Max, et al.
Publicado: (2020)

Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review
por: B. Tata, Emiliene, et al.
Publicado: (2020)

Primary care and mental health providers’ perceptions of implementation of pharmacogenetics testing for depression prescribing
por: Vest, Bonnie M., et al.
Publicado: (2020)

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
por: Tuteja, Sony, et al.
Publicado: (2021)

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting
por: Cavallari, LH, et al.
Publicado: (2017)

Study on the mechanism of Danshen-Guizhi drug pair in the treatment of ovarian cancer based on network pharmacology and in vitro experiment
por: Qin, Chongzhen, et al.
Publicado: (2022)

The Potential Utility of Pharmacogenetic Testing in Psychiatry
por: Gardner, Kathryn R., et al.
Publicado: (2014)

Variant Interpretation in Current Pharmacogenetic Testing
por: Luvsantseren, Sally, et al.
Publicado: (2020)

The Utility of Pharmacogenetics Testing in Psychiatric Populations
por: Jürgens, Gesche
Publicado: (2021)

EXPERIENCE OF PHARMACOGENETIC TESTING IN THE TREATMENT OF ANTIPSYCHOTICS
por: Kaydan, M., et al.
Publicado: (2023)

ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics
por: López-Fernández, Luis A.
Publicado: (2018)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
por: Olivera, Gladys, et al.
Publicado: (2019)

Ensuring equity: Pharmacogenetic implementation in rural and tribal communities
por: Leitch, Tianna M., et al.
Publicado: (2022)

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing
por: Varughese, Lisa A., et al.
Publicado: (2021)

A Mixed-Methods Protocol to Identify Best Practices for Implementing Pharmacogenetic Testing in Clinical Settings
por: Sperber, Nina R., et al.
Publicado: (2022)

Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia
por: Wu, Angela, et al.
Publicado: (2023)

Pharmacogenetic testing in the Veterans Health Administration: Policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
por: Vassy, Jason L., et al.
Publicado: (2018)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Editorial: Pharmacogenetics Research and Clinical Applications: An International Landscape of the Accomplishments, Challenges, and Opportunities
por: Zgheib, Nathalie K., et al.
Publicado: (2020)

Best–worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy
por: Salloum, Ramzi G., et al.
Publicado: (2022)

Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice
por: Russmann, Stefan, et al.
Publicado: (2020)

Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece
por: Ragia, Georgia, et al.
Publicado: (2023)

Positive perception of pharmacogenetic testing for psychotropic medications
por: Lanktree, Matthew B, et al.
Publicado: (2014)

Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions
por: Böhm, Ruwen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_reh288sl00vh0uef5rkqp478t0